Balentine LLC’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-299
| Closed | -$53K | – | 968 |
|
|
2020
Q1 | $53K | Buy |
299
+31
| +12% | +$5.5K | ﹤0.01% | 175 |
|
|
2019
Q4 | $51K | Buy |
268
+182
| +212% | +$34.6K | ﹤0.01% | 187 |
|
|
2019
Q3 | $14K | Buy |
86
+36
| +72% | +$5.86K | ﹤0.01% | 294 |
|
|
2019
Q2 | $8K | Buy |
50
+8
| +19% | +$1.28K | ﹤0.01% | 381 |
|
|
2019
Q1 | $6K | Hold |
42
| – | – | ﹤0.01% | 403 |
|
|
2018
Q4 | $6K | Buy |
42
+9
| +27% | +$1.29K | ﹤0.01% | 386 |
|
|
2018
Q3 | $6K | Buy |
+33
| New | +$6K | ﹤0.01% | 335 |
|
|
2018
Q1 | – | Sell |
-975
| Closed | -$159K | – | 588 |
|
|
2017
Q4 | $159K | Sell |
975
-68
| -7% | -$11.1K | 0.01% | 148 |
|
|
2017
Q3 | $214K | Buy |
1,043
+77
| +8% | +$15.8K | 0.02% | 113 |
|
|
2017
Q2 | $235K | Buy |
966
+51
| +6% | +$12.4K | 0.02% | 99 |
|
|
2017
Q1 | $219K | Buy |
915
+75
| +9% | +$18K | 0.02% | 100 |
|
|
2016
Q4 | $176K | Sell |
840
-1,374
| -62% | -$288K | 0.02% | 105 |
|
|
2016
Q3 | $510K | Buy |
2,214
+508
| +30% | +$117K | 0.07% | 37 |
|
|
2016
Q2 | $394K | Buy |
1,706
+7
| +0.4% | +$1.62K | 0.08% | 35 |
|
|
2016
Q1 | $455K | Sell |
1,699
-13
| -0.8% | -$3.48K | 0.12% | 29 |
|
|
2015
Q4 | $535K | Sell |
1,712
-201
| -11% | -$62.8K | 0.11% | 29 |
|
|
2015
Q3 | $520K | Buy |
1,913
+1,630
| +576% | +$443K | 0.1% | 26 |
|
|
2015
Q2 | $86K | Sell |
283
-38
| -12% | -$11.5K | 0.01% | 104 |
|
|
2015
Q1 | $96K | Buy |
+321
| New | +$96K | 0.02% | 95 |
|